Supply of nuclear medicine in the news
Lutetium-177 used for advanced prostate cancer
Showing 2181 - 2200 of 2566 results
Lutetium-177 used for advanced prostate cancer
The Biosciences team undertakes the radiolabelling of chemical, biochemical. biological or material vector for the purpose of radiotracing in living systems.
ANSTO has signed a strategic agreement with the Australian National University and sets the relationship between the two organisations, who collaborate on important projects, such as the fusion energy project ITER and space research, well into the future.
ANSTO is responsible for the Little Forest Legacy Site (LFLS) located within the ANSTO Buffer Zone boundary. This site, formerly known as the Little Forest Burial Ground (LFBG), was used by the Australian Atomic Energy Commission (AAEC) during the 1960’s to dispose of waste containing low levels of radioactivity and beryllium oxide (non-radioactive) in a series of shallow trenches. There has been regular monitoring of the site since 1966 and the results have been reported in ANSTO’s environmental monitoring reports.
ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.
The first pilot project at the Australian Synchrotron takes place following a Memorandum of Understanding between nandin and Swinburne University of Technology and Design Factory Melbourne (DFM).
ANSTO publishes amendments to annual reports on this page.
Senior electronics engineer from SESAME visits following donation of instrumentation to the Middle East's synchrotron in Jordan.
Nuclear safety expert discusses Fukushima
Australian and New Zealand Society of Nuclear Medicine recognises Nigel Lengkeek
Highlighted at radiation protection congress
Incredible Insect Competition Winners of 2021. Digital colouring-in competition.
Researchers from La Trobe University have used the Australian Synchrotron to help identify a key mechanism in how SARS-CoV-2 damages lung tissue.